LifeMD, Inc. (NASDAQ:LFMD) Receives $13.17 Average PT from Analysts

LifeMD, Inc. (NASDAQ:LFMD) has received an average rating of “Moderate Buy” from the nine research firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $13.1667.

Several research analysts have recently weighed in on the stock. Zacks Research upgraded shares of LifeMD from a “strong sell” rating to a “hold” rating in a research note on Friday, September 5th. Wall Street Zen cut LifeMD from a “buy” rating to a “hold” rating in a report on Saturday, August 2nd. Weiss Ratings restated a “sell (d-)” rating on shares of LifeMD in a research note on Wednesday, October 8th. HC Wainwright cut their price objective on LifeMD from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Thursday, August 7th. Finally, Lake Street Capital decreased their target price on LifeMD from $18.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, August 6th.

Insider Buying and Selling

In other LifeMD news, insider Nicholas P. Alvarez sold 75,000 shares of the company’s stock in a transaction on Wednesday, September 10th. The shares were sold at an average price of $5.92, for a total value of $444,000.00. Following the transaction, the insider directly owned 605,000 shares in the company, valued at $3,581,600. The trade was a 11.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 18.40% of the stock is currently owned by company insiders.

Institutional Trading of LifeMD

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in LifeMD by 6.7% in the 3rd quarter. Vanguard Group Inc. now owns 2,226,871 shares of the company’s stock valued at $15,120,000 after buying an additional 140,749 shares during the last quarter. Royce & Associates LP grew its position in shares of LifeMD by 3.5% in the first quarter. Royce & Associates LP now owns 1,155,231 shares of the company’s stock valued at $6,284,000 after purchasing an additional 39,240 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its stake in shares of LifeMD by 5.4% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 981,894 shares of the company’s stock worth $5,342,000 after purchasing an additional 50,600 shares during the period. Geode Capital Management LLC increased its stake in shares of LifeMD by 7.9% during the second quarter. Geode Capital Management LLC now owns 925,173 shares of the company’s stock worth $12,603,000 after purchasing an additional 67,440 shares during the period. Finally, Jump Financial LLC lifted its holdings in LifeMD by 205.0% during the 2nd quarter. Jump Financial LLC now owns 515,052 shares of the company’s stock worth $7,015,000 after purchasing an additional 346,171 shares during the last quarter. Institutional investors own 35.52% of the company’s stock.

LifeMD Price Performance

Shares of LFMD opened at $4.63 on Wednesday. The company has a current ratio of 0.77, a quick ratio of 0.72 and a debt-to-equity ratio of 9.21. The company’s fifty day simple moving average is $6.07 and its 200 day simple moving average is $8.72. LifeMD has a 1-year low of $4.13 and a 1-year high of $15.84. The company has a market cap of $219.55 million, a price-to-earnings ratio of -22.05 and a beta of 1.57.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.